|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2000-1-18
|
|
pubmed:abstractText |
The American Diabetes Association has recently defined a new category of abnormal glucose homeostasis called "impaired fasting glucose" (IFG), where glucose levels do not meet the criteria of diabetes but are too high to be considered normal. We determined whether endothelial dysfunction is a characteristic of subjects with IFG.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0149-5992
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2055-60
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10587842-Acetylcholine,
pubmed-meshheading:10587842-Blood Glucose,
pubmed-meshheading:10587842-Endothelium, Vascular,
pubmed-meshheading:10587842-Fasting,
pubmed-meshheading:10587842-Forearm,
pubmed-meshheading:10587842-Glucose Intolerance,
pubmed-meshheading:10587842-Humans,
pubmed-meshheading:10587842-Male,
pubmed-meshheading:10587842-Middle Aged,
pubmed-meshheading:10587842-Nitroprusside,
pubmed-meshheading:10587842-Regional Blood Flow,
pubmed-meshheading:10587842-Vasodilator Agents
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
In vivo endothelial dysfunction characterizes patients with impaired fasting glucose.
|
|
pubmed:affiliation |
Department of Medicine, University of Helsinki, Finland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
